Spesolimab

• Target:

  Interleukin|||IL Receptor

• Related Pathways:

  Immunology/Inflammation

• Purity:

  >95%

• Bioactivity:

  Spesolimab (BI 655130) is an anti-interleukin-36 receptor antibody. It plays a crucial role in the immune system by reducing biomarkers associated with congenital Th1/Th17 and neutrophil pathways. Spesolimab can be used to study systemic pustular psoriasis, palmar and plantar impetigo (PPP), and atopic dermatitis.

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  2097104-58-8